Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Reinisch

Showing results (181-190 of 352) with videos related to

Pageof 36
Sort By:
Inflammatory Bowel Diseases|September 26, 2024
Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened PatientsMathieu Uzzan, Georgi Georgiev, Laurent Peyrin-Biroulet, et al.
Inflammatory Bowel Diseases|May 4, 2007
Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitisWalter Reinisch, William J Sandborn, Mohan Bala, et al.
Gut|August 27, 2013
Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trialLaurent Peyrin-Biroulet, Walter Reinisch, Jean-Frederic Colombel, et al.
Gastroenterology|November 9, 2011
Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitisWilliam J Sandborn, Gert van Assche, Walter Reinisch, et al.
Journal of Crohn'S & Colitis|December 28, 2016
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional TherapyGeert D'Haens, Walter Reinisch, Jean-Frederic Colombel, et al.
Journal of the American Academy of Dermatology|August 12, 2009
Extracorporeal photopheresis: past, present, and futureRobert Knobler, Mark L Barr, Daniel R Couriel, et al.
Advances in Therapy|August 10, 2024
Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect ComparisonsWalter Reinisch, Gil Y Melmed, Hiroshi Nakase, et al.
Gastroenterology|April 11, 2015
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled TrialPaul Moayyedi, Michael G Surette, Peter T Kim, et al.
Inflammatory Bowel Diseases|May 11, 2012
Extracorporeal photopheresis (ECP) in patients with steroid-dependent Crohn's disease: an open-label, multicenter, prospective trialWalter Reinisch, Robert Knobler, Paul J Rutgeerts, et al.
European Journal of Gastroenterology & Hepatology|February 1, 2003
Heterogeneous expression and regulation of CD40 in human hepatocellular carcinomaMargareta Holub, Schaker M Zakeri, Cornelia Lichtenberger, et al.
Pageof 36

Showing results (181-190 of 352) with videos related to

Sort By:
Pageof 36
Inflammatory Bowel Diseases|September 26, 2024
Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened PatientsMathieu Uzzan, Georgi Georgiev, Laurent Peyrin-Biroulet, et al.
Inflammatory Bowel Diseases|May 4, 2007
Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitisWalter Reinisch, William J Sandborn, Mohan Bala, et al.
Gut|August 27, 2013
Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trialLaurent Peyrin-Biroulet, Walter Reinisch, Jean-Frederic Colombel, et al.
Gastroenterology|November 9, 2011
Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitisWilliam J Sandborn, Gert van Assche, Walter Reinisch, et al.
Journal of Crohn'S & Colitis|December 28, 2016
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional TherapyGeert D'Haens, Walter Reinisch, Jean-Frederic Colombel, et al.
Journal of the American Academy of Dermatology|August 12, 2009
Extracorporeal photopheresis: past, present, and futureRobert Knobler, Mark L Barr, Daniel R Couriel, et al.
Advances in Therapy|August 10, 2024
Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect ComparisonsWalter Reinisch, Gil Y Melmed, Hiroshi Nakase, et al.
Gastroenterology|April 11, 2015
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled TrialPaul Moayyedi, Michael G Surette, Peter T Kim, et al.
Inflammatory Bowel Diseases|May 11, 2012
Extracorporeal photopheresis (ECP) in patients with steroid-dependent Crohn's disease: an open-label, multicenter, prospective trialWalter Reinisch, Robert Knobler, Paul J Rutgeerts, et al.
European Journal of Gastroenterology & Hepatology|February 1, 2003
Heterogeneous expression and regulation of CD40 in human hepatocellular carcinomaMargareta Holub, Schaker M Zakeri, Cornelia Lichtenberger, et al.
Pageof 36